Daily SPAC Update – January 9, 2025

by | Jan 9, 2025

FutureTech II (FTII) Trust Overpayments Continue. Aimfinity Investment (AIMAU) Sets Extension Vote. Western Acquisition (WAVS) Extension Approved. Global Star (GLST) Deal Vote Set. RANG/RANGU Separate Trading on Jan 13.

Boardroom Alpha SPAC Resources
Full SPAC Listing
SPAC SEC Filings
Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

EXTENSION VOTES
AIMAU – AIMFINITY INVESTMENT CORP I * vote January 9, 2025 -> extend to October 28, 2025

SPAC VOTE RESULTS
WAVS – WESTERN ACQUISITION VENTURES CORP * Extend to Apr 11, 2025

SPAC DEAL & EXTENSION VOTES SET
GLST – Global Star Acquisition Inc * DEAL VOTE SET: Feb 03, 2025 * trust $11.45

SEPARATE WARRANTS/RIGHTS
RANG on Jan 13

OTHER SPAC NEWS
CLBR – COLOMBIER ACQUISITION CORP II * Merger Agreement
BRKH – BURTECH ACQUISITION CORP * PIPE Update
FTII – FUTURETECH II ACQUISITION CORP * Redemption Overpayment from Trust
QETA – QUETTA ACQUISITION CORP * Vote Adjourned

YESTERDAY’S TOP SPAC GAINERS
7.38% ~ $ 12.95 | WINV – WinVest Acquisition Corp. (Announced)
4.27% ~ $ 12.20 | WAVS – Western Acquisition Ventures Corp. (Announced)
4.20% ~ $ 11.90 | HSPO – Horizon Space Acquisition I Corp. (Announced)
2.51% ~ $ 12.25 | FTII – Future Tech II Acquisition Corp. (Announced)
2.03% ~ $ 12.04 | AQU – Aquaron Acquisition Corp. (Announced)

YESTERDAY’S TOP SPAC LOSERS
-11.11% ~ $ 8.96 | LATG – LatAmGrowth SPAC (Announced)
-7.92% ~ $ 10.81 | GLLI – Globalink Investment Inc. (Announced)
-6.58% ~ $ 12.49 | IPXX – Inflection Point Acquisition Corp. II (Announced)
-6.30% ~ $ 10.86 | HAIA – Healthcare AI Acquisition Corp. (Announced)
-2.13% ~ $ 11.50 | IGTA – Inception Growth Acquisition Ltd (Announced)

LATEST SPAC IPO PERFORMANCE
Dec 23 | $ 10.01 | TDAC – Translational Development Acquisition Corp.
Dec 19 | $ 10.02 | RANG – Range Capital Acquisition Corp.
Dec 12 | $ 9.95 | DRDB – Roman DBDR Acquisition Corp. II
Dec 12 | $ 10.02 | MLAC – Mountain Lake Acquisition Corp.
Dec 10 | $ 10.08 | JACS – Jackson Acquisition Co II

Recent Analysis

Daily SPAC Update – January 15, 2025

$150M Plum Acquisition IV and $50M Ribbon Acquisition SPAC IPOs. Aimfinity (AIMAU) and Quetta (QETA) Extensions Approved. Bowen (BOWN) + Qianzhi BioTech Deal Approved. 

Daily SPAC Update – January 14, 2025

Cohen Circle (CCIR) LOI with Ukranian Firm. BRKH DeSPACs to Blaize (BZAI). PPYA Extension Vote. Aimfinity Extends to Oct 2025. Bowen Acquisition (BOWN) Forward Purchase Agreement. 

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.